Redox Experimental Medicine journal cover

Redox Experimental Medicine is an open-access, peer-reviewed journal publishing redox research that advances our understanding of the effect of redox processes on human health and disease.

Aberration in redox processes has a profound impact on the normal physiology of humans, with an implication in many diseases. Redox Experimental Medicine will serve as an essential publication for the international scientific community to translate experimental knowledge to redox-based preventive and/or therapeutic interventions, with a view to advancing health. The journal will publish basic and translational articles which have potential therapeutic relevance, as well as pre-clinical and clinical studies.

Redox Experimental Medicine will cover all main areas of human pathophysiology, with special but not limited focus on healthy ageing and age-related diseases, cancer, cardiac and circulatory diseases, inflammatory-driven chronic diseases, endocrine and metabolic diseases, pregnancy, perinatal and newborn pathology, neurodegeneration, and infectious diseases. Redox-related nutrition and pharmacology will perfectly fit into the scope of the journal as well.

Redox Experimental Medicine will consider for publication all articles which are scientifically sound. We welcome the following article types: research papers (including clinical trials), reviews, brief communications, debates and commentaries. The journal will also publish occasional invited special issues. The journal will accept quality observational studies, following thorough review.

The journal is newly launched, and as such does not yet have an impact factor. We aim to achieve indexing in PubMed as soon as possible, after which point all published articles will be indexed retrospectively. We also aim to achieve indexing in Web of Science so that the journal receives an impact factor as soon as possible, but unlikely to be sooner than 4 years after launch.

The Editorial Board aims to provide rapid and constructive peer review and will aim to give you a first decision within three weeks. The journal operates single anonymous peer review.